Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03038152 · ClinicalTrials.gov registry record · Phase 4
Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery
A Phase 4 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT03038152: Completed Phase 4 study, sponsored by M.D. Anderson Cancer Center.
NCT03038152 is a Phase 4 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03038152, a Phase 4 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
This phase IV trial studies the side effects of the Magseed magnetic marker and how well it works in locating lymph nodes in the underarm area in patients with breast cancer undergoing surgery. Injecting a small metallic marker in or near the lymph node prior to surgery may help the surgeon locate the lymph nodes during surgery without using radiation.
Interventions
- PROCEDURE Axillary Lymph Node Dissection
- DEVICE Medical Device
- PROCEDURE Localization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2021-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03038152
The ClinicalTrials.gov registry entry for NCT03038152 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Axillary Lymph Node Dissection is the first listed.
NCT03038152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03038152 about?
NCT03038152 is a clinical study titled "Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery". This phase IV trial studies the side effects of the Magseed magnetic marker and how well it works in locating lymph nodes in the underarm area in patients with breast cancer undergoing surgery. Injecting a small metallic marker in or near the lymph node prior to surgery may help the surgeon locate t...
What is the current status of trial NCT03038152?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2017-04-11. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT03038152?
The interventions under investigation include: Axillary Lymph Node Dissection (PROCEDURE), Medical Device (DEVICE), Localization (PROCEDURE).
Who is sponsoring clinical trial NCT03038152?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.